Revati Shreeniwas

Revati Shreeniwas

Presidente presso Revati, Inc.

63 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Revati Shreeniwas is currently the President of Revati, Inc. and a Member of Continuing Medical Education, Inc. She previously worked as a Principal at Scios, Inc. and CV Therapeutics, Inc., as well as the Vice President of Clinical Research & Development at Alvine Pharmaceuticals, Inc. She also held the position of Principal at The Trustees of Columbia University in The City of New York and was a Professor at Stanford University.
Additionally, she served as the Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and is currently the Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022.

Posizioni attive di Revati Shreeniwas

SocietàPosizioneInizio
Corporate Officer/Principal -
Revati, Inc. Presidente 01/01/2004
Tutte le posizioni attive di Revati Shreeniwas

Precedenti posizioni note di Revati Shreeniwas

SocietàPosizioneFine
BRIGHT MINDS BIOSCIENCES INC. Direttore Tecnico/Scientifico/R&S 01/12/2022
SOLENO THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 01/06/2020
Direttore Tecnico/Scientifico/R&S 01/01/2017
Stanford University Corporate Officer/Principal -
The Trustees of Columbia University in The City of New York Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Revati Shreeniwas

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Revati Shreeniwas

Relazioni

14

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SOLENO THERAPEUTICS, INC.

Health Technology

BRIGHT MINDS BIOSCIENCES INC.

Health Technology

Aziende private6

Health Technology

Consumer Services

Health Technology

Health Technology

Revati, Inc.

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Revati Shreeniwas